Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure

Gastroenterology

Volumn 94, Issue 5 PART 1, 1988, Pages 1186-1192

  O'Grady, John G ^a   Gimson, A E S ^a   O'Brien, C J ^a   Pucknell, A ^a   Hughes, R D ^a   Williams, Roger ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; HALOTHANE; PARACETAMOL;

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOPERFUSION; HEPATITIS B; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; CHARCOAL; CHILD; CLINICAL TRIALS; FEMALE; HALOTHANE; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HEPATITIS, VIRAL, HUMAN; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023920204     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(88)90011-x     Document Type: Article

References (26)

1. Haemoperfusion over microencapsulated adsorbent in a patient with hepatic coma
2. Clinical experience with charcoal and resin hemoperfusion
3. Biochemical correlations of reversal of hepatic coma treated with charcoal hemoperfusion
4. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required?
5. Fulminant hepatic failure
6. Acute hepatic failure—in special relation to treatment
7. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure
8. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats
9. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats
10. Factors possibly influencing the effects of hemoperfusion in fulminant hepatic failure rats
11. Charcoal haemoperfusion in the treatment of fulminant hepatic failure
12. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion and polyacrylonitrile haemodialysis
13. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure
14. Earlier charcoal haemoperfusion in fulminant hepatic failure
15. The management of fulminant hepatic failure
16. Foreword
17. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure
18. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparision between incidence, types and prognosis
19. Liver transplantation for acute and subacute hepatic failure in adults
20. Liver transplantation: the initial experience of a Canadian centre
21. Orthotopic liver transplantation in a patient with Amanita poisoning
22. Orthotopic liver transplantation for acute fulminant Wilson's disease
23. Indications and results of liver transplantation in acute hepatitic failure
24. Fulminant Wilson's disease treated with postdilutional hemofiltration and orthotopic liver transplantation
25. Role of activated carbon hemoperfusion in the recovery of livers exposed to ischemic damage
26. Utilisation of activated carbon hemoperfusion to assist recovery of ischemically-damaged liver allografts